Anja Meißner

Cardiovascular Effects of Chronic GIPR and GLP-1R Agonism in Lean and Diet-Induced Obese Mice: Sex Differences and Dose-Dependent Remodeling

Glucose‑dependent insulinotropic polypeptide (GIP) and glucagon‑like peptide‑1 (GLP‑1) regulate metabolism and are increasingly targeted in therapies for type 2 diabetes and obesity. Although GLP‑1 receptor agonists confer cardiovascular benefits, the cardiovascular effects of GI...